Delcath Systems Inc (DCTH)

[AKsquared]

Biotech is a completely different animal. Sometimes they work, most times they don't. Less than 5% of oncology trials make it from phase 1 to approval. Its is a looooong, expensive, frustrating process that can take decades - as in the case with Delcath. Trials are a cumbersome BEAST. Especially when they deal with life and death.

Knowing & understanding the implications of what it means to have cancer, I think we can all agree that there is an enormous demand for this product. I for one, was shocked to find out that targeted administration of cancer drugs to specific organs was not yet FDA Approved.

Having had first hand experience waiting on FDA Approval for 5 yrs (non-oncology) I empathize with Delcath and what the company has had to endure. But the toxic MMs make my blood boil, its horrendous - I'm obviously not happy with what I've seen the past few weeks, but I believe in the product & certainly think many other companies out there would agree.

The FDA would be providing a disservice to our country if Delcath doesn't get approved. Think about it - patients would have to go to Europe to get life saving treatment.....seems pretty silly.

Things aren't black-and-white.

I recently heard that Tesla has a higher valuation than Ford.... riddle me this..... is Tesla profitable?